학술논문
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
Document Type
Article
Author
Kogure, Yasunori; Handa, Hiroshi; Ito, Yuta; Ri, Masaki; Horigome, Yuichi; Iino, Masaki; Harazaki, Yoriko; Kobayashi, Takahiro; Abe, Masahiro; Ishida, Tadao; Ito, Shigeki; Iwasaki, Hiromi; Kuroda, Junya; Shibayama, Hirohiko; Sunami, Kazutaka; Takamatsu, Hiroyuki; Tamura, Hideto; Hayashi, Toshiaki; Akagi, Kiwamu; Shinozaki, Tomohiro; Yoshida, Takahiro; Mori, Ikuo; Iida, Shinsuke; Maeda, Takahiro; Kataoka, Keisuke
Source
In Blood 6 June 2024 143(23):2401-2413
Subject
Language
ISSN
0006-4971